A dual PI3K/mTOR inhibitor as potential therapeutic option for vulvar cancer

被引：0
|
作者：
Rodrigues, Lara [1 ]
Rodrigues, Bruna [1 ]
Giudice, Fernanda [1 ]
Baiocchi, Glauco [1 ]
Soares, Fernando Augusto [1 ]
Martins, Vilma [1 ]
Rocha, Rafael Malagoli [1 ]
机构：
[1] FUNDACAO AC CAMARGO, Sao Paulo, Brazil
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-2662
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2662
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Identification of 3-amidoquinoline derivatives as PI3K/mTOR dual inhibitors with potential for cancer therapy
    Zhang, Jiankang
    Ma, Xiaodong
    Lv, Xiaoqing
    Li, Ming
    Zhao, Yanmei
    Liu, Guoqiang
    Zhan, Shuyu
    RSC ADVANCES, 2017, 7 (04): : 2342 - 2350
  • [22] The PI3K/AKT/mTOR Pathway as a Therapeutic Target in Endometrial Cancer
    Slomovitz, Brian M.
    Coleman, Robert L.
    CLINICAL CANCER RESEARCH, 2012, 18 (21) : 5856 - 5864
  • [23] The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer
    Mabuchi, Seiji
    Kuroda, Hiromasa
    Takahashi, Ryoko
    Sasano, Tomoyuki
    GYNECOLOGIC ONCOLOGY, 2015, 137 (01) : 173 - 179
  • [24] The Dual PI3K/mTOR Inhibitor BEZ235 Is Effective in Lung Cancer Cell Lines
    Herrera, Vivian Arrias
    Zeindl-Eberhart, Evelyn
    Jung, Andreas
    Huber, Rudolf Maria
    Bergner, Albrecht
    ANTICANCER RESEARCH, 2011, 31 (03) : 849 - 854
  • [25] Evaluation of a Dual PI3K/mTOR Inhibitor PF-04691502 against Bladder Cancer Cells
    Shang, Xiaosong
    Na, Xinyu
    Wang, Lei
    Yang, Zhiqin
    Ren, Pengpeng
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [26] PI3K/mTOR Dual Inhibitor VS-5584 Preferentially Targets Cancer Stem Cells
    Kolev, Vihren N.
    Wright, Quentin G.
    Vidal, Christian M.
    Ring, Jennifer E.
    Shapiro, Irina M.
    Ricono, Jill
    Weaver, David T.
    Padval, Mahesh V.
    Pachter, Jonathan A.
    Xu, Qunli
    CANCER RESEARCH, 2015, 75 (02) : 446 - 455
  • [27] Dietary flavonoid fisetin: A novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management
    Adhami, Vaqar Mustafa
    Syed, Deeba Nadeem
    Khan, Naghma
    Mukhtar, Hasan
    BIOCHEMICAL PHARMACOLOGY, 2012, 84 (10) : 1277 - 1281
  • [28] A novel PI3K/mTOR dual inhibitor, CMG002, overcomes the chemoresistance in ovarian cancer
    Choi, Hye Joung
    Heo, Jin Hyung
    Park, Ju Yeon
    Jeong, Ju Yeon
    Cho, Hyeon Ju
    Park, Kyung Soon
    Kim, Se Hwa
    Moon, Yong Wha
    Kim, Jin Sung
    An, Hee Jung
    GYNECOLOGIC ONCOLOGY, 2019, 153 (01) : 135 - 148
  • [29] Novel Nanococktail of a Dual PI3K/mTOR Inhibitor and Cabazitaxel for Castration-Resistant Prostate Cancer
    Huang, Yee
    Xue, Xiangdong
    Li, Xiaocen
    Jia, Bei
    Pan, Chong-Xian
    Li, Yuanpei
    Lin, Tzu-Yin
    ADVANCED THERAPEUTICS, 2020, 3 (10)
  • [30] Evaluation of a Dual PI3K/mTOR Inhibitor PF-04691502 against Bladder Cancer Cells
    Shang, Xiaosong
    Na, Xinyu
    Wang, Lei
    Yang, Zhiqin
    Ren, Pengpeng
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
12345